KLK4 Antibodies

Santa Cruz Biotechnology provides a broad selection of KLK4 monoclonal antibodies for investigating KLK4 protein function and expression. KLK4 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLK4, or Kallikrein-related peptidase 4, is a serine protease that plays a significant role in regulating various physiological processes, including tissue remodeling and inflammation. KLK4 expression is particularly relevant in prostate cancer research, where it is often associated with disease progression. Research focused on KLK4 continues to reveal important insights about its role in cancer development and potential therapeutic applications. Understanding KLK4 function and regulation can lead to the identification of new therapeutic targets and biomarkers for cancer diagnosis and treatment. Studying KLK4 expression patterns helps researchers better understand its involvement in normal development and disease states. Santa Cruz Biotechnology monoclonal antibodies for KLK4 support researchers worldwide in advancing scientific understanding of cancer biology and therapeutic development.